Secreted testosterone circulates in the blood in its free form or bound to carrier proteins. Some large observational and randomized studies have supported this conclusion, whereas others have suggested a cardioprotective role for testosterone. Cardiovascular disease (CVD) is the leading cause of death globally.1 Various factors increase the risk of CVD, including diabetes, obesity, hypertension, dyslipidemia, and increasing age. I just released another video that walks you through exactly how to lose weight rapidly without wrecking your hormones or crashing your energy. How you access hormones can greatly depend on your proximity to a medical provider who prescribes HRT, your insurance coverage, or your ability to pay out of pocket. It’s important to note that while this combination of medications is commonly referred to as masculinizing HRT, not all people who take testosterone seek these changes to "masculinize" themselves. Because everybody metabolizes hormones differently, medical providers often work with patients interested in microdosing to find a dose that feels right for them. This is because existing estrogen levels do not prohibit testosterone levels from rising if you are taking HRT, meaning someone can still get the desired physical and emotional changes from T without an estrogen blocker. Masculinizing HRT usually consists of taking a form of testosterone therapy, the most common of which is an injectable synthetic form of the hormone called testosterone cypionate. Monitoring changes in HRV over time is a great way to not only improve your health but also a novel response when on testosterone replacement therapy. This improved autonomic function reduces cardiovascular risk by fostering a more resilient and adaptable heart. TRT boosts HRV by normalizing testosterone levels, enhancing the balance between the body's stress and relaxation responses. It is believed that TRT may improve HRV levels by directly enhancing cardiovascular health in addition to changes in the autonomic nervous system. In a clinical trial, men were provided 250mg of testosterone replacement therapy (TRT) for 9 weeks, and HRV was assessed with a 24-hour Holter monitor. But if the heart beats too fast for no clear reason, or stays elevated for a long time, it may be a sign of a problem. Sometimes, men on TRT report a faster heartbeat, also known as tachycardia. Testosterone Replacement Therapy (TRT) can improve energy, mood, and muscle strength in men with low testosterone. During treatment, doctors should follow up regularly to check testosterone levels and make sure they stay in the normal range. This should include checking for heart disease, blood pressure problems, and other risk factors. These symptoms may be caused by changes in how the nervous system reacts to the hormone or by an increased metabolism. A fast heart rate is not one of the most common side effects of TRT, but it can happen. Some studies show that TRT can raise resting heart rate in certain men, while others do not find a strong link. Several studies have looked at how TRT affects heart rate. Mature osteoblasts have been shown to increase bone formation and increase BMD in both women and men. Almost all studies demonstrate that androgen upregulates the expression of androgen receptors in osteoblasts . Osteoporosis medications include bisphosphonates, receptor activator of nuclear factor kappa-B ligand inhibitors, estrogen agonists/antagonists, parathyroid hormone analogues, and monoclonal antibodies 20,21. The major cause of osteoporosis in women has erroneously been thought to be estrogen deficiency due to menopause, while in men, age-related testosterone deficiency . Most peer-reviewed publications about osteoporosis and testosterone, and the most cited related papers, have discussed osteoporosis in men. Subjects enrolled in these studies were followed over a long period of time and then divided into cases or controls, based on development of coronary events. In contrast, men in the highest quartile of serum T in the MrOS study had the lowest incidence of CVD events over 5 years of follow-up . These longitudinal analyses, therefore, relate endogenous T levels to the development of disease over time. The authors also found higher vascular and all-cause mortality among men with low plasma T levels when compared with men without androgen deficiency.
